James R ODell
Overview
Explore the profile of James R ODell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
3008
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stamp L, Frampton C, Newcomb J, ODell J, Mikuls T, Dalbeth N
Arthritis Care Res (Hoboken)
. 2024 Dec;
PMID: 39711080
Objective: The aim of this research was to determine how common gout flares are after ceasing anti-inflammatory prophylaxis. Methods: A rapid literature review and meta-analysis were undertaken. PubMed was searched...
2.
Sanchez C, Campeau A, Liu-Bryan R, Mikuls T, ODell J, Gonzalez D, et al.
Sci Rep
. 2024 Oct;
14(1):24598.
PMID: 39426967
Urate-lowering treatment (ULT) to target with xanthine oxidase inhibitors (XOIs) paradoxically causes early increase in gouty arthritis flares. Because delayed reduction in flare burden is mechanistically unclear, we tested for...
3.
Barry A, Helget L, Androsenko M, Wu H, Kramer B, Newcomb J, et al.
Arthritis Rheumatol
. 2024 Jun;
76(10):1552-1559.
PMID: 38925627
Objective: Initiating urate-lowering therapy (ULT) in gout can precipitate arthritis flares. There have been limited comparisons of flare risk during the initiation and escalation of allopurinol and febuxostat, administered as...
4.
Helget L, Davis-Karim A, ODell J, Mikuls T, Newcomb J, Androsenko M, et al.
Am J Kidney Dis
. 2024 Jun;
84(5):538-545.
PMID: 38906504
Rationale & Objective: We conducted a prespecified examination of the efficacy and safety of allopurinol and febuxostat administered using a treat-to-target strategy in trial participants with chronic kidney disease (CKD)....
5.
Sanchez C, Campeau A, Liu-Bryan R, Mikuls T, ODell J, Gonzalez D, et al.
Res Sq
. 2024 May;
PMID: 38766125
Background: Urate-lowering treatment (ULT) to target with xanthine oxidase inhibitors (XOIs) paradoxically causes early increase in gouty arthritis flares. Because delayed reduction in flare burden is mechanistically unclear, we tested...
6.
Baker J, ODell J, England B, Giles J, Newcomb J, George M, et al.
Ann Rheum Dis
. 2024 Jan;
83(4):429-436.
PMID: 38171598
Purpose: To determine if body mass index (BMI) and adipokine levels identify rheumatoid arthritis (RA) patients most likely to benefit from initiation of tumour necrosis factor inhibitors (TNFi) after methotrexate...
7.
Helget L, ODell J, Newcomb J, Androsenko M, Brophy M, Davis-Karim A, et al.
Arthritis Rheumatol
. 2023 Oct;
76(4):638-646.
PMID: 37842953
Objective: Using trial data comparing treat-to-target allopurinol and febuxostat in gout, we examined participant characteristics associated with serum urate (SU) goal achievement. Methods: Participants with gout and SU ≥6.8 mg/dL...
8.
Seifert J, Bemis E, Ramsden K, Lowell C, Polinski K, Feser M, et al.
Arthritis Rheumatol
. 2022 Oct;
75(4):507-516.
PMID: 36259174
Objective: Prevotella copri (P copri), a gut commensal, has been reported to be an immune-relevant organism in individuals with rheumatoid arthritis (RA). This study sought to evaluate anti-P copri (anti-Pc)...
9.
Medcalf M, Bantis L, Shi P, Bhadbhade P, Gundry R, Mikuls T, et al.
Semin Arthritis Rheum
. 2022 Jul;
56:152056.
PMID: 35785666
Objective: Methotrexate (MTX) remains the first-choice disease-modifying therapy in rheumatoid arthritis (RA). However, clinical response is variable, and no reliable predictive biomarkers of efficacy currently exist. In this study, plasma...
10.
Vanderlinden L, Bemis E, Seifert J, Guthridge J, Young K, Demoruelle M, et al.
Front Immunol
. 2022 Jun;
13():881332.
PMID: 35720397
Objective: Higher 25-hydroxyvitamin D (25(OH)D) levels have been associated with reduced risk for autoimmune diseases and are influenced by vitamin D metabolism genes. We estimated genetically-determined vitamin D levels by...